Different from vaccines, monoclonal antibodies boost immunity to help prevent people becoming severely ill from the disease. Two major monoclonal antibodies (Mabs) are used for Covid: Regen-Cov (manufactured by Regeneron Pharmaceuticals) and Sotrovimab (by GlaxoSmithKline). Among the participants who became infected, Regen-Cov reduced the duration of symptomatic disease and the duration of a high viral load," the NEJM article stated. RNZ has been asking the Ministry of Health for the past two weeks about monoclonal antibodies but did not receive a response. "I've written [to] the government to try find out where we are in the process with these monoclonal antibodies, and I haven't got any word back.

Source: New Zealand Herald September 14, 2021 23:00 UTC